_id
691847043c536f8df231780c
Ticker
ZHCLF
Name
Zenith Capital Corp
Exchange
PINK
Address
4820 Richard Road SW, Calgary, AB, Canada, T3E 6L1
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.zenithepigenetics.com
Description
Zenith Capital Corp., a biotechnology investment company, engages in the development of bromodomain inhibitors for the treatment of cancer and other disorders with unmet medical needs. The company's lead compound ZEN-3694, which is in Phase 2 clinical trial for the treatment of metastatic castration resistant prostate cancer in collaboration with Astellas and Newsoara, as well as advanced or metastatic triple-negative breast cancer in collaboration with Pfizer. It has a research and development collaboration agreement with the National Cancer Institute. The company was formerly known as Zenith Epigenetics Corp. and changed its name to Zenith Capital Corp. in August 2016. Zenith Capital Corp. was incorporated in 2013 and is headquartered in Calgary, Canada.
Last Close
0.12
Volume
1249
Current Price
0.12
Change
-0.02
Last Updated
2026-01-08T13:20:38.976Z
Image
https://logo.clearbit.com/www.zenithepigenetics.com
Ipo Date
-
Market Cap
19118000
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-04-30
Revenue
500000
Cost Of Revenue
-
Gross Profit
500000
Operating Expenses
1152000
Operating Income
-652000
Interest Expense
433000
Pretax Income
-1789000
Net Income
-1800000
Eps
-0.011690773203383895
Dividends Per Share
-
Shares Outstanding
159315161
Income Tax Expense
11000
EBITDA
-612000
Operating Margin
-130.4
Total Other Income Expense Net
-1137000
Cash
-
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
-
Property Plant Equipment
-
Total Assets
-
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
-
Equity
-
Bs_currency_symbol
-
Depreciation
27000
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
-
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
-
PE
-
PB
-
ROE
-
ROA
-
FCF
-
Fcf Percent
-
Piotroski FScore
0
Health Score
39
Deep Value Investing Score
0
Defensive Investing Score
3
Dividend Investing Score
1.5
Economic Moat Investing Score
1.5
Garp Investing Score
0
Growth Investing Score
0
Momentum Investing Score
2
Net Net Investing Score
0
Quality Investing Score
0
Value Investing Score
0
Quarters > 0 > quarter
2025-04-30
Quarters > 0 > income Statement > revenue
500000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
500000
Quarters > 0 > income Statement > operating Expenses
1152000
Quarters > 0 > income Statement > operating Income
-652000
Quarters > 0 > income Statement > interest Expense
433000
Quarters > 0 > income Statement > pretax Income
-1789000
Quarters > 0 > income Statement > net Income
-1800000
Quarters > 0 > income Statement > eps
-0.011690773203383895
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
153967575
Quarters > 0 > income Statement > income Tax Expense
11000
Quarters > 0 > income Statement > EBITDA
-612000
Quarters > 0 > income Statement > operating Margin
-130.4
Quarters > 0 > income Statement > total Other Income Expense Net
-1137000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
-
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
-
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
-
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
-
Quarters > 0 > balance Sheet > equity
-
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-
Quarters > 0 > cash Flow > depreciation
27000
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
-
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.011690773203383895
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
-
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2025-01-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
1355000
Quarters > 1 > income Statement > operating Income
-1355000
Quarters > 1 > income Statement > interest Expense
416000
Quarters > 1 > income Statement > pretax Income
-1815000
Quarters > 1 > income Statement > net Income
-1825000
Quarters > 1 > income Statement > eps
-0.011959335402497134
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
152600453
Quarters > 1 > income Statement > income Tax Expense
10000
Quarters > 1 > income Statement > EBITDA
-1314000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-460000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
-
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
-
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
-
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
-
Quarters > 1 > balance Sheet > equity
-
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-
Quarters > 1 > cash Flow > depreciation
26000
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
-
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.011959335402497134
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-
Quarters > 1 > ratios > ROA
-
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2024-10-31
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
1402000
Quarters > 2 > income Statement > operating Income
-1402000
Quarters > 2 > income Statement > interest Expense
383000
Quarters > 2 > income Statement > pretax Income
-1773000
Quarters > 2 > income Statement > net Income
-1781000
Quarters > 2 > income Statement > eps
-0.011674073935403933
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
152560281
Quarters > 2 > income Statement > income Tax Expense
8000
Quarters > 2 > income Statement > EBITDA
-1360000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-371000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
-
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
-
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
-
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
-
Quarters > 2 > balance Sheet > equity
-
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-
Quarters > 2 > cash Flow > depreciation
26000
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
-
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.011674073935403933
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-
Quarters > 2 > ratios > ROA
-
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
39
Quarters > 3 > quarter
2024-07-31
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
1383000
Quarters > 3 > income Statement > operating Income
-1383000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-1938000
Quarters > 3 > income Statement > net Income
-1943000
Quarters > 3 > income Statement > eps
-0.01393990701945704
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
139384000
Quarters > 3 > income Statement > income Tax Expense
5000
Quarters > 3 > income Statement > EBITDA
-1342000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-555000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
15
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
45
Quarters > 3 > balance Sheet > inventories
3
Quarters > 3 > balance Sheet > total Current Assets
6466
Quarters > 3 > balance Sheet > property Plant Equipment
11
Quarters > 3 > balance Sheet > total Assets
8263
Quarters > 3 > balance Sheet > payables
832
Quarters > 3 > balance Sheet > short Term Debt
6908
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
29970
Quarters > 3 > balance Sheet > equity
-21707
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-1943
Quarters > 3 > cash Flow > depreciation
26
Quarters > 3 > cash Flow > change In Working Capital
16
Quarters > 3 > cash Flow > cash From Operations
-722
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-836
Quarters > 3 > cash Flow > cash From Financing
1412
Quarters > 3 > cash Flow > net Change In Cash
-146
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.01393990701945704
Quarters > 3 > ratios > PB
-770.5385359561432
Quarters > 3 > ratios > ROE
8951.029621780992
Quarters > 3 > ratios > ROA
-23514.462059784582
Quarters > 3 > ratios > FCF
-722
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
39
Annuals > 0 > quarter
2025-04-30
Annuals > 0 > income Statement > revenue
500000
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
500000
Annuals > 0 > income Statement > operating Expenses
5292000
Annuals > 0 > income Statement > operating Income
-4792000
Annuals > 0 > income Statement > interest Expense
1585000
Annuals > 0 > income Statement > pretax Income
-7315000
Annuals > 0 > income Statement > net Income
-7349000
Annuals > 0 > income Statement > eps
-0.04805866345593727
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
152917278
Annuals > 0 > income Statement > income Tax Expense
34000
Annuals > 0 > income Statement > EBITDA
-4628000
Annuals > 0 > income Statement > operating Margin
-958.4
Annuals > 0 > income Statement > total Other Income Expense Net
-2523000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
-
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
-
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
-
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
-
Annuals > 0 > balance Sheet > equity
-
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-
Annuals > 0 > cash Flow > depreciation
105000
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-
Annuals > 0 > cash Flow > capital Expenditures
-
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
-
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-0.04805866345593727
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
-
Annuals > 0 > ratios > ROA
-
Annuals > 0 > ratios > FCF
-
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
39
Annuals > 1 > quarter
2024-04-30
Annuals > 1 > income Statement > revenue
-
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
8943000
Annuals > 1 > income Statement > operating Income
-8943000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-10565000
Annuals > 1 > income Statement > net Income
-10596000
Annuals > 1 > income Statement > eps
-0.07602020317970498
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
139384000
Annuals > 1 > income Statement > income Tax Expense
31000
Annuals > 1 > income Statement > EBITDA
-8606000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-1622000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
161
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
60
Annuals > 1 > balance Sheet > inventories
3
Annuals > 1 > balance Sheet > total Current Assets
5633
Annuals > 1 > balance Sheet > property Plant Equipment
15
Annuals > 1 > balance Sheet > total Assets
7410
Annuals > 1 > balance Sheet > payables
736
Annuals > 1 > balance Sheet > short Term Debt
5769
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
27569
Annuals > 1 > balance Sheet > equity
-20159
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
-10596
Annuals > 1 > cash Flow > depreciation
161
Annuals > 1 > cash Flow > change In Working Capital
68
Annuals > 1 > cash Flow > cash From Operations
-4911
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-4475
Annuals > 1 > cash Flow > cash From Financing
9520
Annuals > 1 > cash Flow > net Change In Cash
132
Annuals > 1 > cash Flow > currency_symbol
-
Annuals > 1 > ratios > PE
-0.07602020317970498
Annuals > 1 > ratios > PB
-829.7078228086712
Annuals > 1 > ratios > ROE
52562.1310580882
Annuals > 1 > ratios > ROA
-142995.95141700405
Annuals > 1 > ratios > FCF
-4911
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
39
Annuals > 2 > quarter
2023-04-30
Annuals > 2 > income Statement > revenue
-
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
11252000
Annuals > 2 > income Statement > operating Income
-11252000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-13096000
Annuals > 2 > income Statement > net Income
-13120000
Annuals > 2 > income Statement > eps
-0.09412845089823796
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
139384000
Annuals > 2 > income Statement > income Tax Expense
24000
Annuals > 2 > income Statement > EBITDA
-10964000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-1844000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
29
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
22
Annuals > 2 > balance Sheet > inventories
107
Annuals > 2 > balance Sheet > total Current Assets
1376
Annuals > 2 > balance Sheet > property Plant Equipment
95
Annuals > 2 > balance Sheet > total Assets
3171
Annuals > 2 > balance Sheet > payables
577
Annuals > 2 > balance Sheet > short Term Debt
4431
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
18030
Annuals > 2 > balance Sheet > equity
-14859
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-13120
Annuals > 2 > cash Flow > depreciation
200
Annuals > 2 > cash Flow > change In Working Capital
710
Annuals > 2 > cash Flow > cash From Operations
-8000
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-1256
Annuals > 2 > cash Flow > cash From Financing
9280
Annuals > 2 > cash Flow > net Change In Cash
21
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.09412845089823796
Annuals > 2 > ratios > PB
-1125.6531395114073
Annuals > 2 > ratios > ROE
88296.65522578909
Annuals > 2 > ratios > ROA
-413749.60580258595
Annuals > 2 > ratios > FCF
-8000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
39
Annuals > 3 > quarter
2022-04-30
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
7539000
Annuals > 3 > income Statement > operating Income
-7539000
Annuals > 3 > income Statement > interest Expense
269000
Annuals > 3 > income Statement > pretax Income
-7768000
Annuals > 3 > income Statement > net Income
-7797
Annuals > 3 > income Statement > eps
-0.000057490542890488823
Annuals > 3 > income Statement > dividends Per Share
0
Annuals > 3 > income Statement > shares Outstanding
135622306
Annuals > 3 > income Statement > income Tax Expense
29000
Annuals > 3 > income Statement > EBITDA
-7186000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-229000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
8
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
158000
Annuals > 3 > balance Sheet > inventories
305
Annuals > 3 > balance Sheet > total Current Assets
1000
Annuals > 3 > balance Sheet > property Plant Equipment
222
Annuals > 3 > balance Sheet > total Assets
2877
Annuals > 3 > balance Sheet > payables
1647
Annuals > 3 > balance Sheet > short Term Debt
3479
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
5364
Annuals > 3 > balance Sheet > equity
-13839
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-7797
Annuals > 3 > cash Flow > depreciation
192
Annuals > 3 > cash Flow > change In Working Capital
482
Annuals > 3 > cash Flow > cash From Operations
-847
Annuals > 3 > cash Flow > capital Expenditures
162000
Annuals > 3 > cash Flow > cash From Investing
-256
Annuals > 3 > cash Flow > cash From Financing
1104
Annuals > 3 > cash Flow > net Change In Cash
1
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.000057490542890488823
Annuals > 3 > ratios > PB
-1176.0009191415566
Annuals > 3 > ratios > ROE
56.34077606763495
Annuals > 3 > ratios > ROA
-271.01147028154327
Annuals > 3 > ratios > FCF
-162847
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
31
Valuation > metrics > PE
-0.011690773203383895
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > Net Margin
-3.6
Profitability > final Score
35
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-1.5057736720554273
Risk > final Score
24
Risk > verdict
High
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
50
Prev Profitabilities > 1
50
Prev Profitabilities > 2
55
Prev Risks > 0
17
Prev Risks > 1
15
Prev Risks > 2
21
Prev Liquidities > 0
50
Prev Liquidities > 1
50
Prev Liquidities > 2
52
Updated At
2026-01-20T22:51:41.848Z
Earnings History > 0 > period
2021-07-31
Earnings History > 0 > report Date
2021-10-31
Earnings History > 0 > date
2021-07-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-0.0154
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.0154
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2021-04-30
Earnings History > 1 > report Date
2021-07-31
Earnings History > 1 > date
2021-04-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.0168
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.0168
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2021-01-31
Earnings History > 2 > report Date
2021-04-30
Earnings History > 2 > date
2021-01-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.0117
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.0117
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2020-10-31
Earnings History > 3 > report Date
2021-01-31
Earnings History > 3 > date
2020-10-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.013
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.013
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2020-07-31
Earnings History > 4 > report Date
2020-10-31
Earnings History > 4 > date
2020-07-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.0136
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.0136
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2020-04-30
Earnings History > 5 > report Date
2020-07-31
Earnings History > 5 > date
2020-04-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.0133
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.0133
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2020-01-31
Earnings History > 6 > report Date
2020-04-30
Earnings History > 6 > date
2020-01-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.0175
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.0175
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2019-10-31
Earnings History > 7 > report Date
2020-01-31
Earnings History > 7 > date
2019-10-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.022
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.022
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2019-07-31
Earnings History > 8 > report Date
2019-10-31
Earnings History > 8 > date
2019-07-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.021
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.021
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-04-30
Earnings History > 9 > report Date
2019-07-31
Earnings History > 9 > date
2019-04-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.0134
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.0134
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2019-01-31
Earnings History > 10 > report Date
2019-04-30
Earnings History > 10 > date
2019-01-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.0322
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.0322
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-10-31
Earnings History > 11 > report Date
2019-01-31
Earnings History > 11 > date
2018-10-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.0201
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.0201
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-07-31
Earnings History > 12 > report Date
2018-10-31
Earnings History > 12 > date
2018-07-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.0191
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.0191
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-04-30
Earnings History > 13 > report Date
2018-07-31
Earnings History > 13 > date
2018-04-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.0167
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.0167
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2018-01-31
Earnings History > 14 > report Date
2018-04-30
Earnings History > 14 > date
2018-01-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.0221
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.0221
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2017-10-31
Earnings History > 15 > report Date
2018-01-31
Earnings History > 15 > date
2017-10-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.0207
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.0207
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2017-07-31
Earnings History > 16 > report Date
2017-10-31
Earnings History > 16 > date
2017-07-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.0067
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.0067
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2017-04-30
Earnings History > 17 > report Date
2017-07-31
Earnings History > 17 > date
2017-04-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.0185
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.0185
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2017-01-31
Earnings History > 18 > report Date
2017-04-30
Earnings History > 18 > date
2017-01-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.0189
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.0189
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2016-10-31
Earnings History > 19 > report Date
2017-01-31
Earnings History > 19 > date
2016-10-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.0143
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.0143
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2016-07-31
Earnings History > 20 > report Date
2016-10-31
Earnings History > 20 > date
2016-07-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.0136
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.0136
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2016-04-30
Earnings History > 21 > report Date
2016-07-31
Earnings History > 21 > date
2016-04-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.0089
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.0089
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2016-01-31
Earnings History > 22 > report Date
2016-04-30
Earnings History > 22 > date
2016-01-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.0201
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.0201
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2015-10-31
Earnings History > 23 > report Date
2016-01-31
Earnings History > 23 > date
2015-10-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.0179
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-0.0179
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2015-07-31
Earnings History > 24 > report Date
2015-10-31
Earnings History > 24 > date
2015-07-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.024
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-0.024
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2015-04-30
Earnings History > 25 > report Date
2015-07-31
Earnings History > 25 > date
2015-04-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.0209
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-0.0209
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2015-01-31
Earnings History > 26 > report Date
2015-04-30
Earnings History > 26 > date
2015-01-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.0261
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
-0.0261
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2014-10-31
Earnings History > 27 > report Date
2015-01-31
Earnings History > 27 > date
2014-10-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.0026
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
-0.0026
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2014-07-31
Earnings History > 28 > report Date
2014-10-31
Earnings History > 28 > date
2014-07-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.017
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
-0.017
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2014-04-30
Earnings History > 29 > report Date
2014-07-31
Earnings History > 29 > date
2014-04-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.0421
Earnings History > 29 > eps Estimate
0
Earnings History > 29 > eps Difference
-0.0421
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2014-01-31
Earnings History > 30 > report Date
2014-04-30
Earnings History > 30 > date
2014-01-31
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-0.1021
Earnings History > 30 > eps Estimate
0
Earnings History > 30 > eps Difference
-0.1021
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2013-10-31
Earnings History > 31 > report Date
2014-01-31
Earnings History > 31 > date
2013-10-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.0533
Earnings History > 31 > eps Estimate
0
Earnings History > 31 > eps Difference
-0.0533
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2013-07-31
Earnings History > 32 > report Date
2013-10-31
Earnings History > 32 > date
2013-07-31
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-0.0468
Earnings History > 32 > eps Estimate
0
Earnings History > 32 > eps Difference
-0.0468
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2013-04-30
Earnings History > 33 > report Date
2013-07-31
Earnings History > 33 > date
2013-04-30
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-0.0711
Earnings History > 33 > eps Estimate
0
Earnings History > 33 > eps Difference
-0.0711
Earnings History > 33 > surprise Percent
-
Zenith Capital Corp., a biotechnology investment company, engages in the development of bromodomain inhibitors for the treatment of cancer and other disorders with unmet medical needs. The company's lead compound ZEN-3694, which is in Phase 2 clinical trial for the treatment of metastatic castration resistant prostate cancer in collaboration with Astellas and Newsoara, as well as advanced or metastatic triple-negative breast cancer in collaboration with Pfizer. It has a research and development collaboration agreement with the National Cancer Institute. The company was formerly known as Zenith Epigenetics Corp. and changed its name to Zenith Capital Corp. in August 2016. Zenith Capital Corp. was incorporated in 2013 and is headquartered in Calgary, Canada.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-04-30)
Health Score
* Institutions hold a combined 0.00% of the total shares of Zenith Capital Corp
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2021-07-31
EPS Actual
-0.0154
EPS Estimate
0
EPS Difference
-0.0154
Surprise Percent
0%
(Last Updated 2025-04-30)
(Last Updated 2025-04-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-04-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-04-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.